[{"id":"898413db-97d2-4355-9135-1c43e6af96ba","acronym":"","url":"https://clinicaltrials.gov/study/NCT04458922","created_at":"2021-01-18T21:26:29.307Z","updated_at":"2025-02-25T12:37:37.197Z","phase":"Phase 2","brief_title":"Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma","source_id_and_acronym":"NCT04458922","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" EWSR1 • ATF1 • CREB1","pipe":"","alterations":" ","tags":["EWSR1 • ATF1 • CREB1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Tecentriq (atezolizumab)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 27","initiation":"Initiation: 10/05/2020","start_date":" 10/05/2020","primary_txt":" Primary completion: 11/28/2022","primary_completion_date":" 11/28/2022","study_txt":" Completion: 12/13/2025","study_completion_date":" 12/13/2025","last_update_posted":"2025-02-24"}]